V025-9097 Screening compound: 2-[N-benzyl-1-(4-methylphenyl)formamido]-N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]acetamide

V025-9097 Screening compound: 2-[N-benzyl-1-(4-methylphenyl)formamido]-N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]acetamide
V025-9097 Screening compound: 2-[N-benzyl-1-(4-methylphenyl)formamido]-N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-9097
2-[N-benzyl-1-(4-methylphenyl)formamido]-N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-9097

Molecular Formula

C34H31ClN4O4 (C34 H31 ClN4 O4)

Compound Name

2-[N-benzyl-1-(4-methylphenyl)formamido]-N-[4-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)-1H-imidazol-2-yl]acetamide

IUPAC name

2-[N-benzyl-1-(4-methylphenyl)formamido]-N-[4-(4-chlorophenyl)-1-(34-dimethoxyphenyl)-1H-imidazol-2-yl]acetamide

SMILES

Cc(cc1)ccc1C(N(CC(Nc1nc(-c(cc2)ccc2Cl)cn1-c(cc1)cc(OC)c1OC)=O)Cc1ccccc1)=O

InChI

InChI=1S/C34H31ClN4O4/c1-23-9-11-26(12-10-23)33(41)38(20-24-7-5-4-6-8-24)22-32(40)37-34-36-29(25-13-15-27(35)16-14-25)21-39(34)28-17-18-30(42-2)31(19-28)43-3/h4-19,21H,20,22H2,1-3H3,(H,36,37,40)

InChI Key

DKUJSJNQVIPORT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19825312

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

595.1

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

6.575

Distribution Coefficient, logD

6.575

Water Solubility, LogSw

-6.25

Polar Surface Area

67.654

Acid Dissociation Constant (pKa)

13.40

Base Dissociation Constant (pKb)

2.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.70

V025-9097 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V025-9097 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-9097?
Check Price and Availability of V025-9097, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-9097 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-9097
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-9097
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-9097 available by request